Company: SUPN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001356576-25-000071
Chunk: 135

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 135
---
 the CVRs become probable of achievement.Stock Option The following table summarizes stock option activities:Number ofOptionsWeighted AverageExercise PriceWeightedAverageRemainingContractualTerm (in years)Outstanding, December 31, 20246,719,073 $30.44 5.9Granted 1,101,645 $33.82 Exercised (1,171,953)$23.71 Forfeited (128,117)$33.88 Outstanding, September 30, 2025 (unaudited)6,520,648 $32.15 6.3As of September 30, 2025 (unaudited):Vested and expected to vest6,520,648 $32.15 6.3Exercisable 3,857,789 $31.76 4.8As of December 31, 2024:Vested and expected to vest6,719,073 $30.44 5.9Exercisable4,137,283 $29.54 4.4Restricted Stock UnitsThe following table summarizes restricted stock unit (RSU) activities:Number ofRSUsWeighted AverageGrant Date Fair Value per ShareNonvested, December 31, 2024378,165 $32.48 Granted172,725 $33.50 Vested(137,923)$32.31 Forfeited(15,424)$32.47 Nonvested, September 30, 2025 (unaudited)397,543 $32.98 

27

Performance Share Units The following table summarizes performance share unit (PSU) activities:Performance-Based UnitsMarket-Based UnitsTotal PSUs Number of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNonvested, December 31, 2024324,685 $28.80 20,000 $28.63 344,685 $28.79 Granted246,496 $32.84 — $— 246,496 $32.84 Vested(138,510)$29.96 (20,000)$28.63 (158,510)$29.79 Forfeited(38,800)$30.31 — $— (